Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Forensic Science, Medicine and Pathology
Published in: Forensic Science, Medicine and Pathology 3/2019

01-09-2019 | Autopsy | Images in Forensics

A fatal case of bowel obstruction caused by non-steroidal anti-inflammatory drug enteropathy

Authors: William Ryan Huddleston, Christopher Johnson

Published in: Forensic Science, Medicine and Pathology | Issue 3/2019

Login to get access

Abstract

We report the case of a 34-year-old woman who died after presenting to hospital with a 2-month history of vomiting, abdominal pain and diarrhea. Subsequent inquiries revealed that she had a history of non-steroidal anti-inflammatory drug (NSAID) abuse, and the autopsy revealed stricture formation consistent with being caused by NSAID enteropathy.
Literature
1.
Lang J, Price AB, Levi AJ, Burke M, Gumpel JM, Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41:516–26.CrossRefPubMedPubMedCentral
2.
Adebayo D, Bjarnason I. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Postgrad Med J. 2006;82:186–91.CrossRefPubMedPubMedCentral
3.
Davies NM, Saleh JY, Skjodt NM. Detection and prevention of NSAID-induced enteropathy. Int J Pharm Pharm Sci. 2000;3:137–55.
4.
Reuter BK, Davies NM, Wallace JL. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 1997;112:109–17.CrossRefPubMed
5.
Smale S, Tibble J, Sigthorsson G, Bjarnason I. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001;15:723–38.CrossRefPubMed
6.
Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832–47.CrossRefPubMed
7.
Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3:55–9.CrossRefPubMed
8.
Meling TR, Aabakken L, Røseth A, Osnes M. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol. 1996;31:339–44.CrossRefPubMed
9.
Fortun PJ, Hawkey CJ. Nonsteriodal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol. 2005;21:169–75.CrossRefPubMed
10.
Wallace JL. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol. 2013;19:1861–76.CrossRefPubMedPubMedCentral
11.
Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut. 2003;52:1122–6.CrossRefPubMedPubMedCentral
12.
Rabenstein T, Krauss N, Hahn EG, Konturek P. Wireless capsule endoscopy - beyond the frontiers of flexible gastrointestinal endoscopy. Med Sci Monit. 2002;8:128–32.
13.
14.
Wallace JL. NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies. Br J Pharmacol. 2012;165:67–74.CrossRefPubMedPubMedCentral
15.
Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3:133–41.CrossRefPubMed
16.
Hawkey CJ, Ell C, Simon B, Albert J, Keuchal M, McAlindon M, et al. Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. Clin Gastroenterol Hepatol. 2008;6:536–44.CrossRefPubMed
17.
Satoh H, Amagase K, Takeuchi K. Exacerbation of non-steroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. J Pharmacol Exp Ther. 2012;343:270–7.CrossRefPubMed
18.
Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011;141:1314–22.CrossRefPubMed
19.
Park SC, Chun HJ, Kang CD, Sul D. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol. 2011;17:4647–53.CrossRefPubMedPubMedCentral
20.
Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, et al. Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs. Lancet. 1987;ii:711–4.CrossRef
21.
Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs. Lancet. 1991;337:520.CrossRefPubMed
22.
Kessler WF, Shires GT, Fahey TJ. Surgical complications of non-steroidal anti-inflammatory drug-induced small bowel ulceration. J Am Coll Surg. 1997;185:250–4.PubMed
23.
Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. 2003;124:288–92.CrossRefPubMed
24.
Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients with small or large bowel perforation and haemorrhage. BMJ. 1985;290:347–9.CrossRefPubMed
25.
Silverstein FE, Graham GY, Senior JR, Davies HW, Struthers BJ, Bittman R, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1995;123:241–9.CrossRefPubMed
26.
Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749–54.CrossRefPubMed
27.
Chan FKL, Hung LCT, Suen BY, Wu JC, Lee KC, Leung VK, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med. 2002;347:2104–10.CrossRef
Metadata
Title
A fatal case of bowel obstruction caused by non-steroidal anti-inflammatory drug enteropathy
Authors
William Ryan Huddleston
Christopher Johnson
Publication date
01-09-2019
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 3/2019
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-0079-3

Other articles of this Issue 3/2019

Forensic Science, Medicine and Pathology 3/2019 Go to the issue

Technical Report

Minimizing aerosol bone dust during autopsies

Images in Forensics

Differential intimal staining of the aortic root and pulmonary trunk following pulmonary thromboembolism

Original Article

The role of voluntary and involuntary drug and alcohol consumption and premorbid mental health factors in drug-facilitated sexual assault

Original Article

Detection of cellular material in lip-prints

Case Report

The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung

Images in Forensics

Aortopulmonary fistula related death – forensic implications